Cardiocomm Solutions Stock Market Value
| EKGGF Stock | USD 0 0.00 0.00% |
| Symbol | CardioComm |
CardioComm Solutions 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CardioComm Solutions' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CardioComm Solutions.
| 03/12/2024 |
| 06/10/2024 |
If you would invest 0.00 in CardioComm Solutions on March 12, 2024 and sell it all today you would earn a total of 0.00 from holding CardioComm Solutions or generate 0.0% return on investment in CardioComm Solutions over 90 days. CardioComm Solutions is related to or competes with Sanofi ADR, AstraZeneca PLC, GlaxoSmithKline PLC, Merck, Novartis, Bristol Myers, and Gilead Sciences. CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services relate... More
CardioComm Solutions Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CardioComm Solutions' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CardioComm Solutions upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 47.95 |
CardioComm Solutions Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CardioComm Solutions' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CardioComm Solutions' standard deviation. In reality, there are many statistical measures that can use CardioComm Solutions historical prices to predict the future CardioComm Solutions' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | 0.5683 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CardioComm Solutions' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CardioComm Solutions Backtested Returns
CardioComm Solutions secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13% return per unit of risk over the last 3 months. CardioComm Solutions exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CardioComm Solutions' Risk Adjusted Performance of (0.07), standard deviation of 5.9, and Mean Deviation of 1.43 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.3, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning CardioComm Solutions are expected to decrease by larger amounts. On the other hand, during market turmoil, CardioComm Solutions is expected to outperform it. At this point, CardioComm Solutions has a negative expected return of -0.76%. Please make sure to confirm CardioComm Solutions' information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if CardioComm Solutions performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
CardioComm Solutions has no correlation between past and present. Overlapping area represents the amount of predictability between CardioComm Solutions time series from 12th of March 2024 to 26th of April 2024 and 26th of April 2024 to 10th of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CardioComm Solutions price movement. The serial correlation of 0.0 indicates that just 0.0% of current CardioComm Solutions price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
CardioComm Solutions lagged returns against current returns
Autocorrelation, which is CardioComm Solutions pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CardioComm Solutions' pink sheet expected returns. We can calculate the autocorrelation of CardioComm Solutions returns to help us make a trade decision. For example, suppose you find that CardioComm Solutions has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CardioComm Solutions regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CardioComm Solutions pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CardioComm Solutions pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CardioComm Solutions pink sheet over time.
Current vs Lagged Prices |
| Timeline |
CardioComm Solutions Lagged Returns
When evaluating CardioComm Solutions' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CardioComm Solutions pink sheet have on its future price. CardioComm Solutions autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CardioComm Solutions autocorrelation shows the relationship between CardioComm Solutions pink sheet current value and its past values and can show if there is a momentum factor associated with investing in CardioComm Solutions.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| SGC | Superior Uniform Group | |
| VLN | Valens | |
| GNFT | Genfit | |
| GAIA | Gaia Inc | |
| BLBD | Blue Bird Corp |
Other Information on Investing in CardioComm Pink Sheet
CardioComm Solutions financial ratios help investors to determine whether CardioComm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CardioComm with respect to the benefits of owning CardioComm Solutions security.